According to Technavio’s analyst, the global male infertility market is anticipated to grow at a steady rate and post a CAGR of close to 6% during the forecast period. The rising incidence of prostate cancer will drive the growth prospects for the global male infertility market until the end of 2021. In most cases, the treatment of this cancer requires the removal of the prostate gland, which results in impaired sexual function and infertility in men. Also, seminal vesicles that lie at the base of the bladder are completely removed during the process of prostatectomy and causes loss of semen, which makes the ejaculation impossible. In other cases, when the patient undergoes radiation therapy, the semen produced by radiated prostate cells and seminal vesicles loses its ability to transport well. Such conditions force several individuals to undergo fertility treatments, which drives the adoption rate of infertility treatment.
In terms of geography, the Americas accounted for the majority market share during 2016 and will continue to dominate the market for the next four years. Some of the major factors responsible for the market’s growth in the region includes the rise in infertility and obesity rates, and a lifestyle involving high consumption of liquor, substance abuse, and excessive smoking.
Competitive landscape and key vendors
According to this industry research report, the global male infertility market is highly competitive and diversified due to the presence of a large number of regional and international vendors across the globe. It has been observed that these vendors are increasingly undergoing mergers and acquisitions to extend their product portfolio and geographical presence. In addition, these vendors are increasingly focusing on research and developmental activities and are coming up with innovative products to gain a better competitive edge over their competitors. Intensive competition and excessive capital investment are some of the major challenges faced by the vendors.
Key vendors in this market are -
Zydus Cadila Healthcare
Other prominent vendors in the market include AbbVie, Apricus Biosciences, Aytu BioScience, Bristol-Myers Squibb, CooperSurgical, Medical Electronic Systems, OvaScience, MedITEX, and Xytex Cryo International.
Segmentation by technique and analysis of the male infertility market
DNA Fragmentation Technique
Oxidative Stress Analysis
Sperm Penetration Assay
Computer Assisted Semen Analysis
The DNA fragmentation technique segment accounted for the majority market share during 2016 and will continue to dominate the market for the next four years. One of the major factors responsible for the high rate of adoption of DNA fragmentation technique is its ability to offer an accurate result by measuring the amount of DNA damage. Also, since this technique often serves as an early fertility checkpoint, a large number of individuals go through this male fertility test, which eventually accelerates the rate of revenue generation in the market.
Segmentation by end user and analysis of the male infertility market
· Hospital and research institutes
The fertility clinics segment accounted for the majority market share during 2016 and will continue to dominate the market during the forecasted period. One of the major factors responsible for the market segment's growth is the increasing success rate of the male infertility treatment provided by infertility clinics, which accelerates the rate of inflow of infertility patients and gain popularity in both the domestic as well as the international market.
Key questions answered in the report include
What will the male infertility market size and the growth rate be in 2021?
What are the key factors driving the global male infertility market?
What are the key male infertility market trends impacting the growth of the market?
What are the challenges to market growth?
Who are the key vendors in the global male infertility market?
What are the market opportunities and threats faced by the vendors in the global male infertility market?
What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
What are the key outcomes of the five forces analysis of the global male infertility market?
Technavio also offers customization on reports based on specific client requirement.